173 related articles for article (PubMed ID: 25659856)
1. Radiochemistry, pre-clinical studies and first clinical investigation of 90Y-labeled hydroxyapatite (HA) particles prepared utilizing 90Y produced by (n,γ) route.
Vimalnath KV; Chakraborty S; Rajeswari A; Sarma HD; Nuwad J; Pandey U; Kamaleshwaran K; Shinto A; Dash A
Nucl Med Biol; 2015 May; 42(5):455-464. PubMed ID: 25659856
[TBL] [Abstract][Full Text] [Related]
2. Preparation, evaluation, and first clinical use of 177Lu-labeled hydroxyapatite (HA) particles in the treatment of rheumatoid arthritis: utility of cold kits for convenient dose formulation at hospital radiopharmacy.
Chakraborty S; Vimalnath KV; Rajeswari A; Shinto A; Sarma HD; Kamaleshwaran K; Thirumalaisamy P; Dash A
J Labelled Comp Radiopharm; 2014 Jun; 57(7):453-62. PubMed ID: 24966157
[TBL] [Abstract][Full Text] [Related]
3. Hydroxyapatite (HA) microparticles labeled with (32)P - A promising option in the radiation synovectomy for inflamed joints.
Rajeswari A; Vimalnath KV; Sarma HD; Shetty P; Mohammed SK; Nuwad J; Chakraborty S; Dash A
Appl Radiat Isot; 2016 Oct; 116():85-91. PubMed ID: 27501139
[TBL] [Abstract][Full Text] [Related]
4. Preparation and in vitro stability of (n,gamma) yttrium-90 hydroxyapatite.
Khalid M; Mushtaq A
Appl Radiat Isot; 2005 Apr; 62(4):587-90. PubMed ID: 15701413
[TBL] [Abstract][Full Text] [Related]
5. 175Yb-labeled hydroxyapatite: a potential agent for use in radiation synovectomy of small joints.
Chakraborty S; Das T; Banerjee S; Subramanian S; Sarma HD; Venkatesh M
Nucl Med Biol; 2006 May; 33(4):585-91. PubMed ID: 16720253
[TBL] [Abstract][Full Text] [Related]
6. Preparation and preliminary studies on 177Lu-labeled hydroxyapatite particles for possible use in the therapy of liver cancer.
Chakraborty S; Das T; Sarma HD; Venkatesh M; Banerjee S
Nucl Med Biol; 2008 Jul; 35(5):589-97. PubMed ID: 18589303
[TBL] [Abstract][Full Text] [Related]
7. [
Vimalnath KV; Rajeswari A; Dixit A; Chakravarty R; Sarma HD; Kulkarni S; Jha A; Puranik A; Rangarajan V; Goswami M; Chakraborty S
Cancer Biother Radiopharm; 2024 Feb; 39(1):82-91. PubMed ID: 38265675
[No Abstract] [Full Text] [Related]
8. Palliative care of bone pain due to skeletal metastases: Exploring newer avenues using neutron activated (45)Ca.
Chakravarty R; Chakraborty S; Ram R; Nair KV; Rajeswari A; Sarma HD; Dash A
Nucl Med Biol; 2016 Feb; 43(2):140-9. PubMed ID: 26872438
[TBL] [Abstract][Full Text] [Related]
9. Tracer level radiochemistry to clinical dose preparation of (177)Lu-labeled cyclic RGD peptide dimer.
Chakraborty S; Sarma HD; Vimalnath KV; Pillai MR
Nucl Med Biol; 2013 Oct; 40(7):946-54. PubMed ID: 23850487
[TBL] [Abstract][Full Text] [Related]
10. Practicality of production of ³²P by direct neutron activation for its utilization in bone pain palliation as Na₃[³²P]PO₄.
Vimalnath KV; Shetty P; Chakraborty S; Das T; Chirayil V; Sarma HD; Jagadeesan KC; Joshi PV
Cancer Biother Radiopharm; 2013 Jun; 28(5):423-8. PubMed ID: 23611187
[TBL] [Abstract][Full Text] [Related]
11. Preparation and pre-clinical study of 177Lu-labelled hydroxyapatite for application in radiation synovectomy of small joints.
Abbasi I; Ishfaq M; Sohaib M
Q J Nucl Med Mol Imaging; 2011 Aug; 55(4):458-68. PubMed ID: 21068710
[TBL] [Abstract][Full Text] [Related]
12. Formulation, preclinical evaluation, and preliminary clinical investigation of an in-house freeze-dried EDTMP kit suitable for the preparation of 177Lu-EDTMP.
Das T; Sarma HD; Shinto A; Kamaleshwaran KK; Banerjee S
Cancer Biother Radiopharm; 2014 Dec; 29(10):412-21. PubMed ID: 25409337
[TBL] [Abstract][Full Text] [Related]
13. Preparation and preliminary biological evaluation of 177Lu-labelled hydroxyapatite as a promising agent for radiation synovectomy of small joints.
Chakraborty S; Das T; Banerjee S; Sarma HD; Venkatesh M
Nucl Med Commun; 2006 Aug; 27(8):661-8. PubMed ID: 16829766
[TBL] [Abstract][Full Text] [Related]
14. In vivo comparative study of hydroxyapatite labeled with different radioisotopes: evaluation of the scintigraphic images.
Couto RM; De Barboza MF; De Souza AA; Muramoto E; Mengatti J; De Araújo EB
Cell Mol Biol (Noisy-le-grand); 2010 May; 56(2):6-11. PubMed ID: 20525452
[TBL] [Abstract][Full Text] [Related]
15. 166Ho-labeled hydroxyapatite particles: a possible agent for liver cancer therapy.
Das T; Chakraborty S; Sarma HD; Venkatesh M; Banerjee S
Cancer Biother Radiopharm; 2009 Feb; 24(1):7-14. PubMed ID: 19216630
[TBL] [Abstract][Full Text] [Related]
16. Reactor production and electrochemical purification of (169)Er: a potential step forward for its utilization in in vivo therapeutic applications.
Chakravarty R; Chakraborty S; Chirayil V; Dash A
Nucl Med Biol; 2014 Feb; 41(2):163-70. PubMed ID: 24480267
[TBL] [Abstract][Full Text] [Related]
17. Preparation and studies with 90Y-labelled particles for use in radiation synovectomy.
Pandey U; Mukherjee A; Chaudhary PR; Pillai MR; Venkates M
Appl Radiat Isot; 2001 Oct; 55(4):471-5. PubMed ID: 11545499
[TBL] [Abstract][Full Text] [Related]
18. Facile radiochemical separation of clinical-grade
Chakravarty R; Chakraborty S; Jadhav S; Dash A
Nucl Med Biol; 2019; 68-69():58-65. PubMed ID: 30770227
[TBL] [Abstract][Full Text] [Related]
19. Bioevaluation of (90)Y-labeled particles in animal model of arthritis.
Pandey U; Bapat K; Sarma HD; Dhami PS; Naik PW; Samuel G; Venkatesh M
Ann Nucl Med; 2009 Jun; 23(4):333-9. PubMed ID: 19437098
[TBL] [Abstract][Full Text] [Related]
20. Formulation and purification of therapeutic dose of
Chakravarty R; Chakraborty S; Dash A
Appl Radiat Isot; 2017 Mar; 121():1-5. PubMed ID: 28012419
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
